-
IUPAC Name:N-[(1-cyclobutyl-1H-pyrazol-4-yl)methyl]-2,3,5,6-tetrafluoro-4-methoxyanilineFor a custom pack size or bulk
please drop us a line:Enquire -
-
IUPAC Name:1,2,4,5-tetrafluoro-3-nitro-6-[(4-phenylbut-3-yn-1-yl)oxy]benzene
Supplier Lead time Price, $ Pack ChemBridge Corp.Ships from: United StatesTo:14 days 68 Description: Name: 1,2,4,5-tetrafluoro-3-nitro-6-[(4-phenyl-3-butyn-1-yl)oxy]benzene; Stereochemistry: achiral; Compound state: solidFor a custom pack size or bulk
please drop us a line:Enquire -
-
IUPAC Name:5-{4-[2,6-difluoro-4-(2-methoxyethoxy)phenyl]piperazin-1-yl}-3-methyl-3H,4H,7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one
Supplier Lead time Price, $ Pack MedChemExpressShips from: United StatesTo:10 days 345 Description: Names: Basroparib; STP1002; Product Description: Basroparib is an orally active poly (ADP-ribose) polymerase (PARP) inhibitor with an IC 50 of 5.8 nM for TNKS1 , exhibiting antitumor activity .; Target: PARP; CAS: 1858179-75-5MedChemExpress EUShips from: SwedenTo:10 days 363 Description: Names: Basroparib; STP1002; Product Description: Basroparib is an orally active poly (ADP-ribose) polymerase (PARP) inhibitor with an IC50 of 5.8 nM for TNKS1, exhibiting antitumor activity; Target: PARP; CAS: 1858179-75-5For a custom pack size or bulk
please drop us a line:Enquire -
-
IUPAC Name:1-phenyl-N-(2,3,6-trifluoro-4-{[3-(2-{[(3S,5S)-5-fluoropiperidin-3-yl]amino}pyrimidin-4-yl)pyridin-2-yl]oxy}phenyl)methanesulfonamide
Supplier Lead time Price, $ Pack MedChemExpressShips from: United StatesTo:10 days 460 Description: Names: G-5758; Product Description: G-5758 is an orally available IRE1α inhibitor with an IC 50 of 38 nM for XBP1s. G-5758 is well tolerated in multiple myeloma models (KMS-11) at oral doses up to 500 mg/kg in rats. G-5758 exhibits pharmacodynamics comparable to that of induced IRE1 knockdown .; Target: IRE1;Liposome; CAS: 2413455-99-7MedChemExpress EUShips from: SwedenTo:10 days 484 Description: Names: G-5758; Product Description: G-5758 is an orally available IRE1α inhibitor with an IC50 of 38 nM for XBP1s. G-5758 is well tolerated in multiple myeloma models (KMS-11) at oral doses up to 500 mg/kg in rats. G-5758 exhibits pharmacodynamics comparable to that of induced IRE1 knockdown; Target: IRE1;Liposome; CAS: 2413455-99-7For a custom pack size or bulk
please drop us a line:Enquire -